Abstract: A thermally vulcanizable pressure-sensitive adhesive comprising a chemically precrosslinked, pressure-sensitively adhesive polybutadiene-polyurethane and ground sulfur, which during the heating phase remains pressure-sensitively adhesive, does not liquefy and hence in this phase, in which the vulcanization has not yet started and the curing has not yet commenced, has shear strength at least under load to moderate low, is able to transmit forces and hence to perform holding, a process for producing it, an adhesive tape comprising this pressure-sensitive adhesive, and a process for producing the adhesive tape.

Abstract: Methods and systems for diagnosing functional and/or structural abnormalities of the heart preceding heart failure, and for predicting the risk of developing heart failure, in a subject comprising measuring a cardiac troponin in a sample and comparing the measurement to a reference value. Other markers, including GDF15 and IGFBP7 are also measured in some embodiments.

Abstract: Methods and systems for diagnosing functional and/or structural abnormalities of the heart preceding heart failure, and for predicting the risk of developing heart failure, in a subject comprising measuring a cardiac troponin in a sample and comparing the measurement to a reference value. Other markers, including GDF15 and IGFBP7 are also measured in some embodiments.

Abstract: A thermally vulcanizable pressure-sensitive adhesive comprising a chemically precrosslinked, pressure-sensitively adhesive polybutadiene-polyurethane and ground sulfur, which during the heating phase remains pressure-sensitively adhesive, does not liquefy and hence in this phase, in which the vulcanization has not yet started and the curing has not yet commenced, has shear strength at least under load to moderate low, is able to transmit forces and hence to perform holding, a process for producing it, an adhesive tape comprising this pressure-sensitive adhesive, and a process for producing the adhesive tape.

Abstract: In a method and a computer for identifying a group of persons, from a number of persons, to whom at least one contrast agent has been applied during an examination which was carried out in an imaging system with which medical images of each of the number of persons were produced, existing examination data provided for each of the number of persons are used to determine to which of those persons the at least one contrast agent was applied. The persons to whom at least one contrast agent was applied during the examination are identified as a group of persons. For each person in the group, person-specific contrast agent data are determined that include at least identification information identifying the person to whom the at least one contrast agent was applied, and contrast agent information identifying the fact that the at least one contrast agent was applied. A designation of each person in the group of persons is stored with that person's corresponding person-specific contrast agent data in a register.

Abstract: Methods and systems for diagnosing functional and/or structural abnormalities of the heart preceding heart failure, and for predicting the risk of developing heart failure, in a subject comprising measuring a cardiac troponin in a sample and comparing the measurement to a reference value. Other markers, including GDF15 and IGFBP7 are also measured in some embodiments.

Abstract: Methods and systems for diagnosing functional and/or structural abnormalities of the heart preceding heart failure, and for predicting the risk of developing heart failure, in a subject comprising measuring a cardiac troponin in a sample and comparing the measurement to a reference value. Other markers, including GDF15 and IGFBP7 are also measured in some embodiments.

Abstract: In vitro methods for obtaining an indication of damage in the broncheoalveolar compartment of the lung comprising, measuring C-terminal proSP-B in a bodily fluid sample and comparing the level measured to a reference level of C-terminal proSP-B, wherein an increased level of C-terminal proSP-B is indicative of damage in the broncheoalveolar compartment of the lung.